Lithium augmentation in venlafaxine non-responders: an open study. European psychiatry : the journal of the Association of European Psychiatrists. [Eur Psychiatry] Journal article

Thirteen major depressive patients not responding to a 4-week venlafaxine 300 mg treatment were eligible for a 4-week open trial of lithium addition. Two patients had to stop lithium for a possible moderate serotonin syndrome and five patients became responders, including one dramatic response and two semi-rapid responses.

European psychiatry : the journal of the Association of European Psychiatrists. [Eur Psychiatry]

Adult
Antidepressive Agents
Cyclohexanols
Delayed-Action Preparations
Depressive Disorder
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Lithium Compounds
Male
Middle Aged
Personality Inventory
Research Support, Non-U.S. Gov't
Sulfates
Treatment Outcome